Literature DB >> 21678063

Influence of chromosome 22q11.2 microdeletion on postoperative calcium level after cardiac-correction surgery.

Li Shen1, Haitao Gu, Dongjing Wang, Chi Yang, Zhengfeng Xu, Hua Jing, Yongzhong Jiang, Yibing Ding, Huacheng Hou, Zhijuan Ge, Shilin Chen, Xuming Mo, Long Yi.   

Abstract

One of the most common constitutional chromosomal abnormalities, 22q11.2 microdeletion (del22q11.2) syndrome has diverse medical complications, such as congenital heart defect, hypocalcaemia, and immune deficiency, which require coordinated multidisciplinary care. Until now, the natural history of hypocalcaemia in chromosome del22q11.2 syndrome had been only partly documented, but there has been limited recognition of the importance of calcium status during the postoperative period when altered calcium status may be associated with serious complications. The goals of our study were (1) to delineate the clinical characteristics of serum calcium in patients with del22q11.2 during the postoperative period and (2) to make recommendations for the investigation and management of del22q11.2 patients after cardiac correction. This study included 22 children diagnosed with del22q11.2 syndrome and 110 children without del22q11.2 syndrome from Nanjing Children's Hospital. Clinical examinations and blood ionized calcium testing were reviewed retrospectively. A comparative study of postoperative calcium levels and complications of del22q11.2 patients with nondeletion patients was performed. Association between postoperative hypocalcaemia and adverse incidents after cardiac correction was also examined. Postoperative hypocalcaemia was observed among 86.4% of del22q11.2 patients and among only 47.3% of nondeletion subjects. The difference was statistically significant (P = 0.0017). Patients with del22q11.2 syndrome also had a much sharper decrease in serum calcium levels during the first 6 h after surgery than nondeletion patients. Postoperative clinical analysis showed that del22q11.2 patients with hypocalcaemia experience more postoperative complications (18 of 19) and greater mortality (5 of 19) after cardiac correction than del22q11.2 patients without normal calcium levels and nondeletion patients. Del22q11.2 children have high susceptibility of hypocalcaemia during the postoperative period, and this low calcium status after cardiac correction may be associated with significant risk of postoperative complications and mortality in patients with del22q11.2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678063     DOI: 10.1007/s00246-011-0012-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  21 in total

1.  Latent hypoparathyroidism in children with conotruncal cardiac defects.

Authors:  B F Cuneo; C B Langman; M N Ilbawi; V Ramakrishnan; A Cutilletta; D A Driscoll
Journal:  Circulation       Date:  1996-05-01       Impact factor: 29.690

2.  Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome.

Authors:  B F Cuneo; D A Driscoll; S S Gidding; C B Langman
Journal:  Am J Med Genet       Date:  1997-03-03

3.  Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients.

Authors:  V M Reddy; D B McElhinney; Z Amin; P Moore; A J Parry; D F Teitel; F L Hanley
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

4.  Course of ionized calcium after thyroidectomy.

Authors:  Alexandre de Andrade Sousa; José Maria Porcaro Salles; João Marcos Arantes Soares; Gustavo Meyer de Moraes; Jomar Rezende Carvalho; Paulo Roberto Savassi Rocha
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

Review 5.  Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.

Authors:  Lisa J Kobrynski; Kathleen E Sullivan
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

6.  Hypocalcemia in a patient with osteosarcoma and 22q11.2 deletion syndrome.

Authors:  Francis J Mussai; Lea C Cunningham; Geoffrey Rezvani; Constantine A Stratakis; James C Reynolds; Galina Nesterova; Robert M Henshaw; Jason E Levine; Lee J Helman; Diane C Arthur; Su Young Kim
Journal:  J Pediatr Hematol Oncol       Date:  2008-08       Impact factor: 1.289

7.  Parathyroid function and growth in 22q11.2 deletion syndrome.

Authors:  Raja Brauner; Agnes Le Harivel de Gonneville; Catherine Kindermans; Jérone Le Bidois; Marguerite Prieur; Stanislaus Lyonnet; Jean-Claude Souberbielle
Journal:  J Pediatr       Date:  2003-05       Impact factor: 4.406

8.  Introduction--databases and the assessment of complications associated with the treatment of patients with congenital cardiac disease.

Authors:  Jeffrey P Jacobs
Journal:  Cardiol Young       Date:  2008-12       Impact factor: 1.093

9.  Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient.

Authors:  Peter C Dyke; Andrew R Yates; Clifford L Cua; Timothy M Hoffman; John Hayes; Timothy F Feltes; Michelle A Springer; Roozbeh Taeed
Journal:  Pediatr Crit Care Med       Date:  2007-05       Impact factor: 3.624

10.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.

Authors:  A K Ryan; J A Goodship; D I Wilson; N Philip; A Levy; H Seidel; S Schuffenhauer; H Oechsler; B Belohradsky; M Prieur; A Aurias; F L Raymond; J Clayton-Smith; E Hatchwell; C McKeown; F A Beemer; B Dallapiccola; G Novelli; J A Hurst; J Ignatius; A J Green; R M Winter; L Brueton; K Brøndum-Nielsen; P J Scambler
Journal:  J Med Genet       Date:  1997-10       Impact factor: 6.318

View more
  7 in total

Review 1.  How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease.

Authors:  Alvin J Chin; Jean-Pierre Saint-Jeannet; Cecilia W Lo
Journal:  Mech Dev       Date:  2012-05-26       Impact factor: 1.882

2.  The effect of hypocalcemia in early childhood on autism-related social and communication skills in patients with 22q11 deletion syndrome.

Authors:  Meghan Muldoon; Opal Y Ousley; Lisa J Kobrynski; Sheena Patel; Matthew E Oster; Samuel Fernandez-Carriba; Joseph F Cubells; Karlene Coleman; Bradley D Pearce
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-30       Impact factor: 5.270

3.  The Impact of 22q11.2 Microdeletion on Cardiac Surgery Postoperative Outcome.

Authors:  Goran Cuturilo; Danijela Drakulic; Ida Jovanovic; Slobodan Ilic; Jasna Kalanj; Irena Vulicevic; Misela Raus; Dejan Skoric; Marija Mijovic; Biljana Medjo; Snezana Rsovac; Milena Stevanovic
Journal:  Pediatr Cardiol       Date:  2017-09-22       Impact factor: 1.655

Review 4.  22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

Authors:  Carolina Putotto; Flaminia Pugnaloni; Marta Unolt; Stella Maiolo; Matteo Trezzi; Maria Cristina Digilio; Annapaola Cirillo; Giuseppe Limongelli; Bruno Marino; Giulio Calcagni; Paolo Versacci
Journal:  Children (Basel)       Date:  2022-05-25

5.  Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome.

Authors:  Arpana Rayannavar; Lorraine E Levitt Katz; Terrence Blaine Crowley; Megan Lessig; Katheryn Grand; Elizabeth Goldmuntz; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-10-01       Impact factor: 2.802

6.  Case fatality rate and associated factors in patients with 22q11 microdeletion syndrome: a retrospective cohort study.

Authors:  Gabriela M Repetto; M Luisa Guzmán; Iris Delgado; Hugo Loyola; Mirta Palomares; Guillermo Lay-Son; Cecilia Vial; Felipe Benavides; Karena Espinoza; Patricia Alvarez
Journal:  BMJ Open       Date:  2014-11-06       Impact factor: 2.692

7.  Genetic abnormalities/syndromes significantly impact perioperative outcomes of conotruncal heart defects.

Authors:  Subhrajit Lahiri; Wernovsky Gil; Salyakina Daria; Gruber Joshua; Jayakar Parul; Burke Redmond; Welch Elizabeth
Journal:  Ann Pediatr Cardiol       Date:  2019-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.